来源:Gangtise投研
Palatin Technologies, Inc. (PTN)2024年第三季度业绩电话会:在2024年第一季度,公司营收580万美元,同比下降3%,净亏损780万美元,较去年增加。现金及现金等价物降至240万美元。公司重点发展肥胖症项目,同时探索眼科等非肥胖项目。二期肥胖症研究预计2025年第一季度出结果,糖尿病肾病研究本季度将发布数据。战略上,公司寻求通过授权、投资和业务合并实现项目价值。眼科项目考虑多种财务策略,预计明年第一季度或有交易达成。当前,五六家大公司关注替代项目,若研究结果积极,可能进行授权许可。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.